■Forum
Forum 1: Acute Pancreatitis Basic, Diagnosis

JULY 11 (13:30−14:10)

Room 3Moderators: Rakesh Kumar Tandon (Pushpawati Singhania Research Institute forLiver, Renal & Digestive Diseases, India)
Yasuhiro Shimizu (Aichi Cancer Center Hospital, Japan)

F―001

Organ Failure and Pancreatic Infection as Determinants of Mortality inPatients with Acute Pancreatitis: A Rationale for a ʻCriticalʼ Categoryof Classification
Max Petrov (Department of Surgery, The University of Auckland, New Zealand)

F―002

Cerulein Induced Acute Pancreatitis Suppress the mTOR Activity
Satoshi Ida (Department of Gastroenterological Surgery, Kumamoto

University!
Institute of Resource Development andAnalysis, Kumamoto University, Japan)

F―003

Can Gut Permeability be Modulated to Prevent Infection of Pancreatic
Necrosis? Effects of Cannabinoids, Cannabinoid Receptors and Pro―
inflammatory Cytokines on a Novel Inflammatory in vitro Model
Abdussalam Alhamoruni (Academic Division of Surgery, School ofGraduate Entry Medicine and Health,
University of Nottingham, UK)

F―004

Protective Effect of Vasoactive Intestinal Peptide (VIP) on Oxidative
Stress―induced Pancreatic Acinar Cell Damage
Nao Fujimori (Department of Medicine and Bioregulatory Science,

Kyushu University, Japan)

F―005

Direct Lymphatic Connections between the Intestine and Pancreas:
Do They Exist?
Benjamin P. T. Loveday (Department of Surgery, University of Auckland,

New Zealand)

Forum 2: Pancreatic Cystic Tumor

JULY 11 (14:10−15:14)

Room 3Moderators: Akio Yanagisawa (Kyoto Prefectural University of Medicine, Japan)
Akihiko Nakaizumi (Kyoto University, Japan)

F―006

New Large Pseudocyst Developing Post Cystogastrostomy Surgery―
Probable Causes and Treatment Options
Dharmesh J. Balsarkar (Department of General Surgery, B.Y.L.Nair

Hospital & T.N.Medical College, India)

F―007

A New Classification System for Primary Intraductal Neoplasms of the
Pancreas
Hiroshi Yamaguchi (Department of Pathology, Saitama Medical University

Saitama International Medical Center, Japan)

F―008

A Case of Invasive Ductal Carcinoma Derived from Branch Duct
Intraductal Papillary Mucinous Neoplasm Showed Almost No Change
in Size during Three and a Half Years
Isaku Yoshioka (Department of Surgery and Science, Toyama

University, Japan)

F―009

Indication of Resection for Intraductal Papillary Mucinous Neoplasm(IPMN): A Prospective Study in a Single―institution
Ryo Yuge (Center of Gastroenterology, Onomichi General Hospital, Japan)

F―010

Indication of Laparoscopic Distal Pancreatectomy for the Pancreatic
Neoplasms
Makoto Shinzeki (Department of Hepato­Biliary­Pancreatic Surgery,

Kobe University Graduate School of Medical
Sciences, Japan)

F―011

A Case of Giant Serous Microcystic Adenoma of the Pancreas Safely
Resected with Preoperative Arterial Embolization
Hidehiro Tajima (Department of Gastroenterologic Surgery, Kanazawa

University, Japan)

F―012

A Case of Gastrointestinal Bleeding from a Ruptured Pseudoaneurysm
within the Pancreas Pseudocyst through Pseudocyst―duodenum
FistulaHisaaki Kita (Department of Medicine, Osaka Koseinenkin Hospital, Japan)

F―013

A Case that Seemed to be Pancreatic Mucinous Cystadenocarcinoma(MCC)
Satoshi Kobayashi (Division of Hepatobiliary and Pancreatic Medical

Oncology, Kanagawa Cancer Center, Japan)

Forum 3: Pancreatic Cancer Surgery

JULY 11 (15:14−16:26)

Room 3Moderators: Ralf Segersvard (Karolinska University Hospital, Sweden)
Masato Kayahara (Kanazawa University, Japan)

F―014

Palliative Distal Pancreatectomy for Patients with Metastatic
Pancreatic Cancers
Masamichi Matsuda (Department of Surgery, Toranomon Hospital, Japan)

F―015

Clinical Significance of Bypass Surgery for Gastrointestinal Outlet
Obstruction in Patients with Unresectable Pancreatic Cancer
Osamu Nakahara (Department of Gastroenterological Surgery,

Kumamoto University, Japan)

F―016

Comparative Study of Results between PPPD and SSPPD for
Pancreatic Head Malignancies
Atsushi Nanashima (Division of Surgical Oncology, Nagasaki University

Hospital, Japan)

F―017

Reducing Intraoperative Blood Loss and Operative Time during
Pancreaticoduodenectomy by Using LigaSureTM Vessel Sealing
SystemKeita Wada (Department of Surgery, Teikyo University School of

Medicine, Japan)

F―018

Posterior Epigastric Artery is the Key Vessel to Preserve Pancreatic
Function Following Pancreaticoduodenectomy with Resection of
Splenic Artery and Splenectomy after Total Gastrectomy
Shugo Mizuno (Department of Hepatobiliary Pancreas and Transplant

Surgery, Mie University, Japan)

F―019

Pancreatic Duct Holder for Facilitating Duct―to―mucosa
Pancreatojejunostomy after Pancreatoduodenectomy
Masanori Sugiyama (Department of Surgery, Kyorin University, Japan)

F―020

Single Drain is Enough for Pancreatic Reconstruction after
Pancreaticoduodenectomy
Kei Horino (Department of Gastroenterological Surgery, Kumamoto

University, Japan)

F―021

Distal Pancreatectomy: Analysis of Techniques for Closure of the
Pancreatic Remnant and Complications
Masafumi Imamura (First Department of Surgery, Sapporo Medical

University School of Medicine, Japan)

F―022

Identification of a Risk Factor for Pancreatic Fistula after Distal
Pancreatectomy Using a Stapler: The Thickness of Pancreatic Stumpis an Important Determinant
Hidetoshi Eguchi (Department of Surgery, Osaka University Graduate

School of Medicine, Japan)

Forum 4: Pancreas Complication JULY 11 (16:26−17:14)

Room 3Moderators: Shuji Isaji (Mie University, Japan)
Yasuyuki Suzuki (Kagawa University, Japan)

F―023

Fatty Liver after Pancreatoduodenectomy and Total Pancreatectomy

F―024

Analysis of Factors Inducing Hepatic Steatosis after

Ichiro Hirai (First Department of Surgery, Yamagata University, Japan)

Pancreaticoduodenectomy
Toshihiko Masui (Department of Hepatobiliarypancreatic Surgery andTransplantation, Kyoto University, Japan)

F―025

The Change of NAFLD Ratio after Pancreatoduodenectomy According
to a Method of Reconstruction, R―Y vs B―II
Mitsugi Shimoda (Second Department of Surgery, Dokkyo Medical

University, Japan)

F―026

Usage of Polyethylene Glycolic Acid Felt with Fibrin Sealant toPrevent Postoperative Pancreatic Fistula in Pancreatic Surgery
Toshiya Ochiai (Department of Surgery, Kyoto Prefectural University of

Medicine, Japan)

F―027

The Effectiveness of the Synbiotics Early Enteral Nutrition!
Nutrition
Support Team Program in Pylorus―preserving
Pancreaticoduodenectomy
Tomoki Furuya (Department of Emergency and Critical Care Medicine,

Akita City Hospital, Japan)

F―028

Accelerated Liquefaction of Pancreatic Necrosis Using Proteolytic
Enzymes: A New Paradigm
Benjamin P. T. Loveday (Department of Surgery, University of Auckland,

New Zealand)

Forum 5: Chronic Pancreatitis Treatment 1 JULY 11 (17:14−17:54)

Room 3Moderators: David Roger Fine (Southampton University Hospitals, UK)
Keisyo Kataoka (Otsu Municipal Hospital, Japan)

F―029

Start with Jaundice and Various Symptoms Come after Steroid
Therapy; A Case Report of AIP
Masato Yamazaki (Department of Surgery, Teikyo University Chiba

Medical Center, Japan)

F―03059 Cases of Pancreatic Diseases Treated by Endoscopy via Minor
Papilla―Its Safety and Efficacy
Tadao Tsuji (Gastroenterology, Saitama City Hospital, Japan)

F―031

Modified Fully Covered Self―expandable Metallic Stents with Anti―
migration Features for Benign Pancreatic―duct Strictures in Advanced
Chronic Pancreatitis; With a Focus on the Safety Profile and Reducing
Migration
Sung!
Hoon Moon (Department of Internal Medicine, Asan Medical

Center, Korea)

F―032

ESWL of Pancreatic Stones in Treating Children with Chronic
Pancreatitis
Grzegorz Oracz (Department of Gastroenterology, Hepatology and Immunology,

The Childrenʼs Memorial Health Institute, Poland)

F―033

Pancreatic Pseudocysts in Children with Chronic Pancreatitis
Jaroslaw Kierkus (Department of Gastroenterology, Hepatology and

Immunology, The Childrenʼs Memorial HealthInstitute, Poland)

Forum 6: Acute Pancreatitis Treatment

JULY 11 (13:30−14:18)

Room 4Moderators: Jeremy Wilson (Liverpool Hospital, UNSW SWS Clinical School, Australia)
Kazunori Takeda (Sendai Medical Center, Japan)

F―034

Three Cases of Infected Walled―off Pancreatic Necrosis Treated withTransmural EUS―guided Drainage and Endoscopic Necrosectomy in aDistrict General Hospital
Hiroyuki Hisai (Department of Gastroenterology, Japan Red Cross Date

General Hospital, Japan)

F―035

Surgical Treatment for Severe Acute Pancreatitis: A Summary of 9
Cases
Taku Aoki (Department of Hepato­Biliary­Pancreatic Surgery,

University of Tokyo, Japan)

F―036

A Case of Severe Acute Pancreatitis Complicating Duodenal
Perforation
Katsunobu Sakurai (Department of Digestive Surgery and Hepato­

Biliary­Pancreatic Surgery, Osaka City General
Hospital, Japan)

F―037Comparison of Nasogastric Feeding and Nasojejunal Feeding for
Severe Acute Pancreatitis
Katsuya Kitamura (Department of Gastroenterology, Showa University

School of Medicine, Japan)

F―038

Efficacy of Nutrition Support Team Supporting Synbiotics Enteral
Nutrition in the Severe Acute Pancreatitis
Tomoki Furuya (Department of Emergency and Critical Care Medicine,

Akita City Hospital, Japan)

F―039

Polymeric or Elemental Nutritional Formula in Patients with Severe
and Critical Acute Pancreatitis? A Meta―Analysis of Randomized
TrialsMax Petrov (Department of Surgery, The University of Auckland, New Zealand)

Forum 7: Chronic Pancreatitis Treatment 2 JULY 11 (14:18−14:58)

Room 4Moderators: Natalya Borisovna Gubergrits (Donetsk National Medical University, Ukraine)
Tetsuya Mine (University of Tokai, Japan)

F―040

Long―term Outcome of Treatment for Pancreatolithiasis with Extra―
corporeal Shockwave Lithotripsy
Satoshi Yamamoto (Internal Medicine, Fujita Health University Second

Teaching Hospital, Japan)

F―041

Standard Steroid Treatment for Autoimmune Pancreatitis
Atsushi Kanno (Division of Gastroenterology, Tohoku University, Japan)

F―042

Corticosteroids Correct Aberrant CFTR Localization in the Duct andRegenerate Acinar Cells in Autoimmune Pancreatitis
Shigeru B. Ko (Department of Gastroenterology, Nagoya University, Japan)

F―043

Biliary and Pancreatic Ductal Hypertension Surgical Therapy inChronic Pancreatitis Patients
Andrii V. Klymenko (Department of Faculty Surgery, Zaporizhzhya State

Medical University, Ukraine)

F―044

Adult Choledochal Cyst with Chronic Pancreatitis―An Uncommon
Presentation
Dharmesh J. Balsarkar (Department of General Surgery, B.Y.L.Nair

Hospital & T.N.Medical College, Indonesia)

Forum 8: IPMN Diagnosis 1 JULY 11 (14:58−15:46)

Room 4Moderators: Naotaka Fujita (Sendai City Medical Center, Japan)
Takao Itoi (Tokyo Medical University, Japan)

F―045

Stromal Hyalinization in Intraductal Papillary Mucinous Neoplasms
Kenichi Hirabayashi (Department of Pathology, Tokai University Schoolof Medicine, Japan)

F―046

Natural History of Intraductal Papillary Mucinous Neoplasms of the
Pancreas Based on EUS Morphological Changes, Focusing on
Coexistent Invasive Ductal Cancer and Malignant Transformation of
IPMN Itself
Eizaburo Ohno (Department of Gastroenterology, Nagoya Unversity, Japan)

F―047

Treatment Strategy for Intraductal Papillary Mucinous Neoplasm of the
Pancreas Based on Malignant Predictive Factors
Atsushi Shimizu (Second Department of Surgery, Wakayama Medical

University, Japan)

F―048

Atypical Epithelial Cells in Fluid Aspirated from Mucinous Cysts of the
Pancreas are a Powerful Predictor of Malignancy
Martha Bishop Pitman (Pathology, Massachusetts General Hospital,

Harvard Medical School, USA)

F―049

Intraductal Papillary―mucinous Neoplasms of the Gastric andIntestinal Types May Have Less Malignant Potential Than the
Pancreatobiliary Type
Naoki Takasu (Department of Gastroenterological, General, Breast andThyroid Surgery, Yamagata University, Japan)

F―050

Management of IPMNs by Endoscopic Ultrasonography
Ken Kamata (Kinki University, Japan)

Forum 9: Endcrine Tumor, Other Pancreatic Tumor

JULY 11 (15:46−16:50)

Room 4Moderators: Hisao Tajiri (Jikei University, Japan)
Shoichiro Sumi (Kyoto University, Japan)

F―051

Pitfalls in the Assessment of Ki―67 Index in Pancreatic Endocrine
Neoplasms
Nobuyuki Ohike (First Department of Pathology, Showa University

School of Medicine, Japan!
Department of Pathology,
Emory University School of Medicine, USA)

F―052

A Case Report of Glucagon―Producing Multiple Pancreatic
Neuroendocrine Tumors That Involved Pancreatic Cystic Lesions
Toru Higashi (Gastroenterology, Tokai University School of Medicine, Japan)

F―053

Successful Control of Intractable Hypoglycemia byRadiopharmaceutical Therapy with Strontium―89 in a 57―year―old
Woman with Malignant Insulinoma and Bone Metastases
Atsushi Naganuma (Hepatobiliary and Pancreatic Oncology Division,

National Cancer Center Hospital, Japan)

F―054

Solid Pseudopapilary Neoplasm of the Pancreas: Sixteen Cases Studyin Our Institution
Takanori Morikawa (Division of Hepato­Biliary­Pancreatic Surgery,

Tohoku University, Japan)

F―055

A Case of Solid Pseudopapillary Neoplasm Presenting with Strong
Fluorodeoxyglucose Uptake on Positron Emission Tomography
Mimicking Malignancy
Masahiko Uchida (Department of Medicine and Bioregulatory Science,

Graduate School of Medical Sciences, Kyushu
University, Japan)

F―056

Value of EUS and EUS―FNA for Diagnosing Metastatic Pancreatic
CancerSusumu Hijioka (Gastroenterology, Aichi Cancer Center Hospital, Japan)

F―057

Spleen―preserving Distal Pancreatectomy with Conservation of theSplenic Artery and Vein
Koji Tezuka (First Department of Surgery, Yamagata University, Japan)

F―058

A Case of Inflammatory Pseudotumor of the Pancreas Associated with
Lymphoplasmacytic Sclerosing Pancreatitis
Sojun Hoshimoto (Department of Surgery, Tokyo Dental College

Ichikawa General Hospital, Japan)

Forum 10: Pancreatic Cancer Diagnosis

JULY 11 (16:50−17:54)

Room 4Moderators: Kenji Yamao (Aichi Cancer Center Hospital, Japan)
Takashi Hatori (Tokyo Womenʼs Medical University, Japan)

F―059

Gender Differences in the Association of Long―standing Diabetes withPancreatic Cancer
Naoto Egawa (Department of Gastroenterology, Tokyo Metropolitan

Komagome Hospital, Japan)

F―060Prognostic Biomarkers in Pancreatic Cancer
Jookyung Park (Department of Surgery, Massachusetts General Hospital,

Harvard Medical School, USA!
Department of Internal
Medicine, Seoul National University Hospital, Korea)

F―061

Long―term Outcome of RT―PCR Based Detection of Minute Cancer
Cells in Peritoneal Lavage Fluid during Surgery in Patients with
Resectable Pancreatic Adenocarcinoma
Hidetoshi Eguchi (Department of Surgery, Osaka Medical Center for

Cancer and Cardiovascular Diseases, Japan)

F―062

Role of 18F―fluorodeoxyglucose Positron Emission Tomography with
Dual Time Point Evaluation in the Diagnosis of Small Pancreatic
Cancer
Keiichi Okano (Department of Gastroenterological Surgery, Kagawa

University, Japan)

F―063

Preoperative Detection of Liver Metastases Secondary to Pancreatic
Cancer: Utility of Gadolinium―ethoxybenzyl―diethylenetriamine
Pentaacetic Acid―enhanced Magnetic Resonance Imaging (Gd―EOB―
DTPA MRI)
Shinya Abe (Department of Gastroenterological Surgery, Kumamoto

University, Japan)

F―064

The Evaluation of MSX2 Expression Level in Brushing Samples during
ERCP Differentiates Malignant from Benign Pancreatic Lesions
Kennichi Satoh (Division of Gastroenterology, Tohoku University, Japan)

F―065

Diagnostic Value of Endoscopic Ultrasound Guided Fine Needle
Aspiration in Patients with Pancreatic Lesions
Ryo Tamura (Department of Medicine and Clinical Oncology, Graduate

School of Medicine, Chiba University, Japan)

F―066

Effectiveness of EUS―FNA in Diagnosing Pancreatic Lesions
Shin Haba (Department of Gastroenterology, Hokkaido University

Graduate School of Medicine, Japan)

Forum 11: Multidisciplinary Approaches

JULY 12 (16:30−17:26)

Room 2Moderators: Masaru Miyazaki (Chiba University, Japan)
Kazuichi Okazaki (Kansai Medical University, Japan)

F―067

Impact of Gemcitabine―based Neoadjuvant Chemoradiotherapy inPatients with Borderline Resectable and Unresectable Locally
Advanced Pancreatic Adenocarcinoma
Masashi Kishiwada (Department of Hepatobiliary Pancreatic andTransplant Surgery, Mie University, Japan)

F―068

A New Viewpoint of Multidisciplinary Therapy in Patients withPrimarily Unresectable Pancreatic Cancer―Chemotherapy Followedby Radical Resection
Shigeaki Sawada (Department of Surgery and Science, University of

Toyama, Japan)

F―069

Renal Function after Preoperative Chemoradiation with Full―doseGemcitabine in Pancreatic Cancer
Satoaki Nakamura (Department of Radiation Oncology, Osaka Medical

Center for Cancer and Cardiovascular Diseases, Japan)

F―070

Chemoradiotherapy in Patients with Unresectable Locally Advanced
Pancreatic Cancer
Kentaro Sudo (Chiba Cancer Center, Japan)

F―071

The Current Status of Treatment for Unresectable Pancreatic Cancer
Hiromune Shimamura (Department of Surgery, Sendai Medical Center, Japan)

F―072

Curative―intent Resection of Pancreatic Cancer in This Decade. Kobe
Experience
Ryo Hosotani (Department of Surgery, Kobe City General Hospital, Japan)

F―073

Infectivity―Enhanced Oncolytic Adenoviral Vectors Expressing
Syngeneic IFN―Alpha for Pancreatic Cancer
Julia Davydova (Department of Surgery, University of Minnesota, USA)

Forum 12: Imaging, Translational Research JULY 12 (17:26−18:14)

Room 2Moderators: Richard M. Charnley (Freeman Hospital, UK)
Yoshiaki Murakami (Hiroshima University, Japan)

F―074

Comparison between CT and EUS in Diagnosis of Local Invasion of
Pancreatic Cancer
Masaki Kuwatani (Department of Gastroenterology, Hokkaido University

Graduate School of Medicine, Japan)

F―075Significance of FDG―PET for the Unresectable Patients withPancreatic Cancer Who Received Chemo―radiation Therapy
Yuko Mataki (Department of Surgical Oncology, Kagoshima University, Japan)

F―076

Differential Diagnosis of IPMNs (Benign or Malignant) by Contrast―
enhanced PET!
CT
Haruo Iguchi (Gastroenterology, Shikoku Cancer Center, Japan)

F―077

Clinicopathological Study of Resected Cases of a Variant ofAutoimmune Pancreatitis Forming a Localized Mass
Shinsuke Koshita (Department of Gastroenterology, Sendai City

Medical Center, Japan)

F―078

The Comprehensive Measurement of Serum Cell Signal
Phosphoproteins is Useful for the Detection of Pancreatic Cancer
Shigetsugu Takano (Department of General Surgery, Chiba University, Japan)

F―079

Genetic Alterations Associated with Clonal Progression of Pancreatic
Cancer Metastasis
Shinichi Yachida (Department of Pathology, The Sol Goldman Pancreatic

Cancer Research Center, Johns Hopkins Medical
Institutions, USA!
Department of Gastroenterological
Surgery, Kagawa University, Japan)

Forum 13: Acute Pancreatitis Treatment, Diagnosis

JULY 12 (14:00−14:56)

Room 3Moderators: John Albert Windsor (University of Auckland, New Zealand)
Akira Andoh (Shiga University of Medical Science, Japan)

F―080

CpG ODN Activates Pancreatic Stellate Cell via Toll―like Receptor 9
Taichi Nakamura (Department of Medicine and Bioregulatory Science,

Graduate School of Medical Sciences, Kyushu
University, Japan)

F―081

Clinicopathological Features of Seronegative Autoimmune
Pancreatitis in Japanese Patients
Nobumasa Mizuno (Departments of Gastroenterology, Aichi Cancer

Center Hospital, Japan)

F―082

Characteristics of Autoimmune Pancreatitis Based on the Serum IgG4
Levels and EUS―FNA Specimens
Takuya Ishikawa (Department of Gastroenterology, Nagoya University

Graduate School of Medicine, Japan)

F―083

Metachronous Extrapancreatic Lesions in Autoimmune Pancreatitis
Kensuke Takuma (Department of Internal Medicine, Tokyo Metropolitan

Komagome Hospital, Japan)

F―084

Gastric Emptying in Autoimmune Pancreatitis Patients
Hajime Anjiki (Department of Internal Medicine, Tokyo Metropolitan

Komagome Hospital, Japan)

F―085

Autoimmune Markers in Children with Chronic Pancreatitis
Grzegorz Oracz (Department of Gastroenterology, Hepatology and Immunology,

The Childrenʼs Memorial Health Institute, Poland)

F―086

Prophylactic Pancreatic Duct Stent to Prevent Post―ERCP
Pancreatitis in Patients with Difficult Biliary Cannulation
Seung Hyo Han (Digestive Disease Center, Department of Internal

Medicine, Soon Chun Hyang University School of
Medicine, Bucheon and Seoul, Korea)

Forum 14: Pancreatic Cancer Basic 1 JULY 12 (14:56−15:52)

Room 3Moderators: Toshio Morohoshi (Showa University, Japan)
Shoji Nakamori (Osaka National Hospital, Japan)

F―087

Nestin Modulates the Migration and Invasion of Pancreatic Cancer
Cells by Regulating Actin and E―cadherin Expression
Yoko Matsuda (Department of Pathology, Integrative Oncological

Pathology, Nippon Medical School, Japan)

F―088

Differences in Migration between Primary and Metastatic PDAC Cells
Jookyung Park (Department of Surgery, Massachusetts General

Hospital & Harvard Medical School, USA)

F―089

Detection of Circulating Tumor Cells (CTCs) in Pancreatic Ductal
Adenocarcinoma (PDAC)
Jookyung Park (Department of Surgery, Massachusetts General

Hospital & Harvard Medical School, USA)

F―090

Interaction between Pancreatic Cancer Cells and Alpha―SMA Positive
Myofibroblast―like Cells Activation in Rat Orthotopic Pancreatic
Cancer Model
Jun Yamao (Department of Surgery, Kansai Medical University, Japan)

F―091

Jagged1 Contributes to the Epithelial―mesenchymal Transition as aTarget Gene of TGF Beta and BMP Signals in Pancreatic Cancer CellLine
Shin Hamada (Division of Gastroenterology, Tohoku University

Graduate School of Medicine, Japan)

F―092

Characterizations of Pancreatic Cancer Cells: KMP―3, KMP―4, KMP―
5, KMP―6. and Growth Inhibition Effect of Selective Prostaglandin
Receptor Antagonist on COX―2 Expressing Cell Pancreatic Cancer
Cell
Makoto Satake (Department of Surgery, Hyogo College of Medicine,Japan!
David Geffen School of Medicine at UCLA, USA)

F―093

IL―32 is a Factor Contributing to Anti―apoptotic Activity of Pancreatic
Cancer Cells
Osamu Inatomi (Division of Gastroenterology, Shiga University of

Medical Science, Japan)

Forum 15: Pancreatic Cancer Chemotherapy

JULY 12 (15:52−16:48)

Room 3Moderators: Haruo Iguchi (Shikoku Cancer Center Research Institute, Japan)
Takuji Okusaka (National Cancer Center Hospital, Japan)

F―094

Low Level of Circulating IL―6 is Associated with Neutropenia ofGemcitabine in Advanced Pancreatic Cancer
Shuichi Mitsunaga (Department of Hepatobiliary Pancreatic Oncology,

National Cancer Center Hospital East, Kashiwa, Japan)

F―095

Radiation Therapy as Adjuvant Therapy for Surgery in Pancreatic
CancerJun Itakura (Department of Surgery, University of Yamanashi, Japan)

F―096

Multidisciplinary Treatment with Neoadjuvant Chemoradiation
Combining with Portal Infusion Chemotherapy for Potentially Curative
Pancreatic Cancer
Koichi Aiura (Department of Surgery, Keio University School of

Medicine, Japan)

F―097

The Strategy of the Adjuvant Chemotherapy after Radical Resection
for Pancreatic Cancer, Which is Better Gemcitabine or S―1?
Shin Takeda (Gastroenterological Surgery, Nagoya University Graduate

School of Medicine, Japan)

F―098

Feasibility and Efficacy of a Tailored S―1 Chemotherapy in Elderly
Patients with Advanced Unresectable Pancreatic Cancer
Satoru Takeji (Division of Gastroenterology, Shikoku Cancer Center, Japan)

F―099

Chemoradiotherapy vs. Gemcitabine―based Chemotherapy in Patientswith Unresectable, Locally Advanced Pancreatic Cancer:
A Retrospective Analysis
Kouki Nio (Division of Hepatobiliary and Pancreatic Oncology, National

Cancer Center Hospital, Japan)

F―100Phase II Study of S―1 with Concurrent Radiotherapy for Locally
Advanced Unresectable Pancreatic Cancer
Hiroyuki Shinchi (Department of Surgical Oncology, Kagoshima

University, Japan)

Forum 16: Pancreatic Cancer Case Report

JULY 12 (16:48−17:44)

Room 3Moderators: Wataru Kimura (Yamagata University, Japan)
Junji Ueda (Kyushu University, Japan)

F―101

Invasive Ductal Adenocarcinoma Developing in the Remnant
Pancreas 14 Years after Distal Pancreatectomy for IPMN Concomitantwith Carcinoma in situ of the Pancreas: A Case Report
Shingo Kozono (Department of Surgery and Oncology, Kyushu

University, Japan)

F―102

Analysis of Prognostic Factor in Long―term Survivors with
Unresectable Advanced Pancreatic Cancer
Takeshi Ishihara (Department of Medicine and Clinical Oncology, Chiba

University, Japan)

F―103

A Case of Pancreatic Adenosquamous Carcinoma Directly Invading
StomachAkira Nishio (Department of Medicine, Osaka Koseinenkin Hospital, Japan)

F―104

Gemcitabine―induced Pericardial Effusion and Right Ventricular
Failure in a Patient with Pancreatic Cancer
Hidenori Kido (Internal Medicine Division, National Cancer Center, Japan)

F―105

Aggressive Surgical Resection after Gemcitabine and S―1
Combination Chemotherapy for Patients with Initially Unresectable
Pancreatic Cancer
Yoshihiro Takahara (Department of General Surgery, Chiba University, Japan)

F―106

Modified FOLFOX―6 Chemotherapy for Gemcitabine and S―1―
refractory Advanced Pancreatic Cancer
Hirotake Komatsu (Division of Hepato­Biliary­Pancreatic Surgery,

Tohoku University, Japan)

F―107

Distal Pancreatectomy with En Bloc Celiac Axis Resection (DP―CAR)
Monitoring Heapatic Arterial Flow with Electromagnetic Flowmetry
during Operation for Safely
Masahiro Ito (Department of Surgery, Fujita Health University, Japan)

Forum 17: Endocrine, Exocrine, Others

JULY 12 (17:44−18:40)

Room 3Moderators: Kyoko Miyasaka (Tokyo Kasei University, Japan)
Terumi Kamisawa (Komagome Hospital, Japan)

F―108

EUS―guided Broad Plexus―neurolysis over the Superior Mesenteric
Artery Using a 25 Gauge Needle
Hiroki Sakamoto (Department of Gastroenterology and Hepatology,

Kinki University School of Medicine, Japan)

F―109

EUS―guided Fiducial Marker Plascement of Pancreas Cancer for
CyberKnife Radiotherapy
Makoto Nishimura (Gastroenterology, Saitama Medical University

International Medical Center, Japan)

F―110

Patterns of Pathologic Lymph Nodal Involvement in the Resected
Pancreatic Head and Body Cancer―Implications for Radiotherapy
Clinical Target Volume Delineation
Katsuyuki Karasawa (Department of Radiology, Tokyo Metropolitan

Cancer and Infectious Diseases Center
Komagome Hospital, Japan)

F―111

Impact of Resecting Pylorus Ring in Pancreaticoduodenectomy to
Reduce Delayed Gastric Emptying: A Prospective Randomized
Controlled Trial of Pylorus―resecting versus Pylorus―preserving
Pancreaticoduodenectomy
Manabu Kawai (Second Department of Surgery, Wakayama Medical

University School of Medicine, Japan)

F―112

Risk Factors for Post―ERCP Pancreatitis: Evaluation in a Prospective
Randomized Trial Comparing the Guidewire Cannulation Techniquewith the Conventional Cannulation Technique
Go Kobayashi (Department of Gastroenterology, Tohoku Bilio!

Bancreatic Intervational Endoscopy Group, Japan)

F―113Interferon Regulatory Factor―2 Plays a Pivotal Role in Exocytosis in
Pancreatic Acinar Cells
Hirosato Mashima (Department of Gastroenterology, Akita University

Graduate School of Medicine, Japan)

F―114

Glycated Albumin Inhibits Insulin Secretion from Islets
Takayuki Shiraki (Department of Second Surgery, Dokkyo Medical

University, Japan)

Forum 18: Others

JULY 12 (14:00−14:56)

Room 4Moderators: Kazuo Inui (Banbuntane Hotokukai Hospital, Fujita Health University, Japan)
Yoshifumi Takeyama (Kinki University, Japan)

F―115

Stage 0 and Stage IA with Tumor Less Than 1 cm in Diameter is
Suitable for an Early Pancreatic Cancer
Akira Kimijima (Department of Gastroenterological Surgery, Tokyo

Womenʼs Medical University, Japan)

F―116

Clinical Features of Elderly Patients with Pancreatic Cancer
Masayuki Furukawa (Department of Gastroenterology, National Kyushu

Cancer Center, Japan)

F―117

Radiographic Classification and Pathological Grade of Portal Vein
Wall Invasion in Pancreatic Head Cancer: Single Institution
Experience
Tsutomu Fujii (Department of Surgery II, Nagoya University Graduate

School of Medicine, Japan)

F―118

Surgical Outcomes of Invasive Pancreatic Cancer in Shikoku Cancer
CenterKoji Ohta (Surgery, Shikoku Cancer Center, Japan)

F―119

Impact of Preoperative Nutritional Factors on the Prognosis andPostoperative Complications of Invasive Adenocarcinoma of the
Pancreas
Takashi Sugae (Department of Surgery II, Nagoya University, Japan)

F―120

Portal Vein Stenting for Gastrointestinal Hemorrhage Caused by Portal
Vein Stenosis after Pancreaticoduodenectomy; A Case Report
Hideyuki Kanemoto (Department of Hepato­biliary­pancreatic Surgery,Shizuoka Cancer Center, Japan)

F―121

Preliminary Results of the Quantitative Analysis in Diagnosing Fibrous
Change of Bright Pancreas Using Real―time Tissue ElastographyⓇ
Yuya Itoh (Department of Gastroenterology, Nagoya University, Japan)

Forum 19: Chronic Pancreatitis Diagnosis

JULY 12 (14:56−16:08)

Room 4Moderators: Keiji Hanada (Onomichi General Hospital, Japan)
Hisato Igarashi (Kyushu University, Japan)

F―122

Clinical Significance of B Cell―activating Factor (BAFF) in
Autoimmune Pancreatitis
Hirofumi Yamanishi (Department of Gastroenterology and Metabology,

Ehime University, Japan)

F―123

Serum IgG4 Levels and IgG4―related Sclerosing Disease
Taku Tabata (Department of Internal Medicine, Tokyo Metropolitan

Komagome Hospital, Japan)

F―124

Positive Response to Steroid Therapy for Autoimmune Pancreatitis
Evaluated with FDG―PET
Yuka Kowazaki (Department of Internal Medicine, Tokyo Metropolitan

Komagome Hospital, Japan)

F―125

Autoimmune Pancreatitis with Inflammatory Bowel Diseases
Toshiharu Ueki (Department of Gastroenterology, Chikushi Hospital,

Fukuoka University, Japan)

F―126

Comparative Discussion of Country―specific Diagnostic Criteria of
Autoimmune Pancreatitis on Our Hospitalʼs 14 Patients
Masafumi Chiba (Division of Gastroenterology and Hepatology,

Department of Internal Medicine, Jikei University
School of Medicine, Japan)

F―127

Autoimmune Pancreatitis in Hungary. A Multicenter Nationwide Study

F―128

Chronic Pancreatitis Induced Massive Dilatation of Pancreatic Duct

László Czakó (First Department of Medicine, University of Szeged, Hungary)with Terminal Bile Duct Stricture―An Interesting Image
Dharmesh J. Balsarkar (Department of General Surgery, B.Y.L.Nair

Hospital & T.N.Medical College, India)

F―129

Chronic Pancreatitis Associated with Abdominal Trauma in Children
Jaroslaw Kierkus (Department of Gastroenterology, Hepatology and

Immunology, The Childrenʼs Memorial HealthInstitute, Poland)

F―130

Comparison of the Mannheim Diagnostic Criteria of Autoimmune
Pancreatitis with Other Diagnostic Criteria Systems
Alexander Schneider (Department of Medicine II , University Medical

Centre Mannheim , Germany)Forum 20: Pancreatic Cancer Basic 2 JULY 12 (16:08−17:04)

Room 4Moderators: Junji Furuse (Kyorin University, Japan)
Minoru Tada (The University of Tokyo, Japan)

F―131

Insig2 was Overexpressed in Pancreatic Cancer and Its Expression
was Induced by Hypoxia
Tadashi Kayashima (Department of Surgery and Oncology, Kyushu

University, Japan)

F―132

Circulating Myeloid Dendritic Cells as a Prognostic Factors in Patientswith Pancreatic Cancer Who Have Undergone Surgical Resection
Tomohisa Yamamoto (Department of Surgery, Kansai Medical

University, Japan)

F―133

The Comprehensive Analysis of Signaling Pathways Related toAnnexin II in Gemcitabine―resistant Pancreatic Cancer: Clinical Valueof Expression Analysis
Shingo Kagawa (Department of General Surgery, Chiba University, Japan)

F―134

Pancreatic Stellate Cells Promote Pancreatic Cancer Proliferation andInvasiveness via Inducing Epithelial―to―mesenchymal Transition
Xiaohua Jiang (Department of General Surgery, Zhongda Hospital,

Southeast University, China)

F―135

Immunological Evaluation of Circulating T Cell and Antigen Presenting
Cell in Patients with Pancreatic Cancer
Satoshi Hirooka (Department of Surgery, Kansai Medical University, Japan)

F―136

The Role of Lumican in the Extracellular Space of Pancreatic Cancer
Tetsushi Yamamoto (Department of Pathology, Integrative Oncological

Pathology, Nippon Medical School, Japan)

F―137

Stimulating Actions of N―6 Polyunsaturated Fatty Acid on Pancreatic
Cancer Cell Proliferation and Invasion
Hitoshi Funahashi (Department of Gastroenterological Surgery, Nagoya

City University, Japan)

Forum 21: Pancreatic Cancer Basic 3 JULY 12 (17:04−17:52)

Room 4Moderators: Hirohide Onishi (Akita University, Japan)
Norihiro Sato (Japanese Red Cross Fukuoka Hospital, Japan)

F―138

MicroRNA Expression in Pancreatic Cancer
Imran Bhatti (Academic Division of Surgery, School of Graduate Entry

Medicine and Health, University of Nottingham, UK)F―139Endoglin (CD105) Expression in Pancreatic Cancer

F―140

Inhibition of Hedgehog Signaling in a PDAC Xenograft Model Inhibits

Masanori Tsujie (Department of Surgery, Osaka National Hospital, Japan)

the Tumor and Its Microenvironment
Dirk Bausch (Department of Surgery, Massachusetts General Hospital &Harvard Medical School, USA)

F―141

HP1γ Mediates Centrosome Separation in Pancreatic Cancer Cells via
Aurora A Phosphorylation: Impact on Chromosomal Instability
Gwen A. Lomberk (GI Research Unit, Division of Gastroenterology andHepatology, Mayo Clinic, USA)

F―142

Discovery of Prognostic Factor Using Proteomic Analysis withFormalin―fixed Paraffin―embedded Tissues of Pancreatic Cancer
Tatsuyuki Takadate (Division of Hepato­Biliary­Pancreatic Surgery,

Tohoku University, Japan)

F―143

Identification of Genes Related to Radioresistance in Pancreatic
Cancer Cell Lines
Shingo Kozono (Department of Surgery and Oncology, Kyushu

University, Japan)

Forum 22: IPMN Diagnosis 2 JULY 12 (17:52−18:40)

Room 4Moderators: Dharmesh J. Balsarkar (B.Y.L.Nair Hospital & T.N.Medical College, India)
Taketo Yamaguchi (Chiba Cancer Center, Japan)

F―144

Main Duct Intraductal Papillary Mucinous Carcinoma of the Pancreas
Preoperatively Confirmed by Cytological Examination of Pancreatic
Juice Collected at ERCP
Kenji Ikezawa (Division of Hepatobiliary and Pancreatic Oncology,

Osaka Medical Center for Cancer and Cardiovascular
Diseases, Japan)

F―145

Pancreatic Juice Cytology in the Diagnosis of Intraductal Papillary
Mucinous Neoplasm
Rintaro Mikata (Department of Medicine and Clinical Oncology, Chiba

University, Japan)

F―146

Utility of Contrast―enhanced Endoscopic Ultrasonography for the
Diagnosis of Intraductal Papillary Mucinous Neoplasm
Seiko Togo (Department of Medicine and Clinical Oncology, Chiba

University, Japan)

F―147

Volumetry and Morphological Analysis of Intraductal Papillary
Mucinous Neoplasm of the Pancreas (IPMN) with Computed
Tomography (CT) and Magnetic Resonance Imaging (MRI)
Saijiro Murayama (Department of Gastroenterological and General

Surgery, Yamagata University, Japan)

F―148

New Preoperative Criteria for Diagnosing Malignant Branch―Type
Intraductal Papillary―Mucinous Neoplasm of the Pancreas
Yuya Nasu (Department of Surgical Oncology, Hokkaido University

Graduate School of Medicine, Japan)

F―149

Natural History of Branch Duct IPMN: A Multicenter Study in Japan
Hiroyuki Maguchi (Center for Gastroenterology, Teine­Keijinkai

Hospital, Japan)